CIK 0001228627 · Non-accelerated filer<br>Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 113516358
- Phone
- (984) 884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-23 | Zaremba Rabourn Amy Head of Fin. Quality Assurance | Sale | −1,641 | $5.20 | $9K | 188,671 |
| 2026-04-23 | Magrath George Chief Executive Officer | Sale | −9,511 | $5.22 | $50K | 1,741,344 |
| 2026-04-23 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Sale | −7,542 | $5.19 | $39K | 509,233 |
| 2026-04-23 | Gagnon Robert E. Chief Financial Officer | Sale | −7,842 | $5.18 | $41K | 592,158 |
| 2026-04-20 | Rodgers Richard J Director | Grant or award | +24,367 | 343,022 | ||
| 2026-04-20 | MANUSO JAMES S J Director | Grant or award | +24,367 | 317,318 | ||
| 2026-04-20 | Graves Adrienne L Director | Grant or award | +24,367 | 127,514 | ||
| 2026-04-20 | Gallagher Cam Director | Grant or award | +24,367 | 2,015,797 | ||
| 2026-04-20 | Benton Susan Director | Grant or award | +24,367 | 243,894 | ||
| 2026-04-20 | Bennett Jean Director | Grant or award | +24,367 | 259,019 | ||
| 2026-04-20 | Ainsworth Sean Director | Grant or award | +24,367 | 321,692 | ||
| 2026-03-16 | SCHACHLE JOSEPH K Chief Operating Officer | Sale | −3,719 | $5.25 | $20K | 300,781 |
| 2026-03-16 | Zaremba Rabourn Amy Head of Fin. Quality Assurance | Sale | −2,816 | $5.25 | $15K | 190,312 |
| 2026-03-16 | Magrath George Chief Executive Officer | Sale | −24,438 | $5.21 | $127K | 1,750,855 |
| 2026-03-16 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Sale | −3,719 | $5.12 | $19K | 516,775 |
| 2026-02-12 | Jayagopal Ashwath Chief Scientific & Dev. Ofc. | Shares withheld for taxes | −5,313 | $3.39 | $18K | 520,494 |
| 2026-01-22 | YERXA BENJAMIN R President | Grant or award | +400,000 | 719,005 | ||
| 2026-01-22 | SCHACHLE JOSEPH K Chief Operating Officer | Grant or award | +250,000 | 304,500 | ||
| 2026-01-22 | Zaremba Rabourn Amy Head of Fin. Quality Assurance | Grant or award | +86,500 | 193,128 | ||
| 2026-01-22 | Magrath George Chief Executive Officer | Grant or award | +483,639 | 1,775,293 |
Page 2 of 7 · 136 trades